Cumberland Pharmaceuticals' antibiotic Vibativ (telavancin) injection has gained approval from China’s National Medical ...

Patients colonized with AMR pathogens showed high risk for infection with the same pathogen for up to 2 years, indicating a time window for decolonization interventions.

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

Ondine’s innovative light-activated antimicrobial treatment has the potential to become the first FDA-approved nasal decolonization treatment for the prevention of surgical site infections. The ...

A new study published in the Journal of Proteomics explores the antibacterial properties of cannabidiol (CBD), revealing its ...

Japan's AMR response from 2013 to 2025 focuses on surveillance, antimicrobial stewardship, infection prevention, and research ...

Researchers have revealed how Staphylococcus aureus bacteria extract iron from hemoglobin—a process crucial to their survival ...

A newborn baby who died in a Glasgow hospital after developing an infection was “stable” the day before she passed away, an ...